Allianz’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.14M Buy
78,498
+1,428
+2% +$115K 0.06% 178
2026
Q1
$6.68M Sell
77,070
-5,877
-7% -$563K 0.07% 154
2025
Q4
$7.97M Buy
82,947
+5,877
+8% +$571K 0.1% 121
2025
Q3
$7.34M Sell
77,070
-2,643
-3% -$243K 0.16% 117
2025
Q2
$6.95M Sell
79,713
-2,403
-3% -$204K 0.16% 115
2025
Q1
$7.38M Sell
82,116
-981
-1% -$87.8K 0.2% 109
2024
Q4
$6.62M Sell
83,097
-13,573
-14% -$1.17M 0.17% 115
2024
Q3
$8.7M Buy
96,670
+12,130
+14% +$1.02M 0.24% 92
2024
Q2
$6.65M Sell
84,540
-9,455
-10% -$775K 0.2% 113
2024
Q1
$8.19M Buy
+93,995
New +$8.02M 0.26% 98

Other funds holding MDT

Allianz's MDT Position: Q2 2026 in Review

Allianz increased its Medtronic (MDT) stake by 1.9% in Q2 2026, buying an estimated $115K and bringing the position to 78,498 shares worth $6.14M. The position accounts for 0.06% of the portfolio, ranked #178.

Allianz first reported a position in MDT in Q1 2024 and has held it in 10 quarters since. The position peaked at $8.7M in Q3 2024. 2,132 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Allianz held 78,498 shares of Medtronic worth $6.14M as of Q2 2026.
  • Allianz bought 1,428 Medtronic shares in Q2 2026, an estimated $115K.
  • Medtronic made up 0.06% of Allianz's portfolio in Q2 2026, its #178 holding.
  • Allianz first reported a position in Medtronic in Q1 2024 and has held it in 10 quarters since.
  • Allianz's Medtronic position peaked at $8.7M in Q3 2024.
  • 2,132 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Allianz's 13F filing for Q2 2026, filed 10 Aug 2026.